3 New Strong Buy Ratings from Top-Rated Analysts: 07/28/2026
Check it out. Here’s a no-paywall peek at the latest from our Strong Buy Stocks from Top Wall Street Analysts screener:
- Bioventus (BVS): The #1-rated stock in our 4600+ stock database
- HF Sinclair (DINO): Tops an A-rated industry with over 20% upside potential
- Marathon Petroleum (MPC): 7 Strong Buys fuel this refining giant
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
The Core of a Winning Portfolio
The 7 Stocks to Buy and Hold Forever aren't just plays for the next quarter – they're built to deliver for decades. These are blue-chip companies with fortress balance sheets, elite dividend track records, and the staying power to outperform in bull and bear markets alike. Some are Dividend Kings, others are on the path there, and all are proven wealth compounding machines. Whether you're after steady income, capital growth, or both, this is the list long-term investors will want in their back pocket.
Download the full list now – before it disappears behind the paywall.
1. HF Sinclair (NYSE: DINO)
As refining margins stabilize and renewable diesel gains traction, this diversified energy company is well-positioned to benefit from both traditional and transitioning energy markets.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $88.30 — get current quote
Max 1-year forecast: $109.00
Why we're watching:
- DINO has strong, bullish coverage among the analysts we track, with 6 Strong Buy, 1 Buy, and 8 Hold recommendations. See all recommendations here
- For example, Goldman Sachs researcher Neil Mehta (a top 5% rated analyst) recently maintained his Strong Buy rating with a price target suggesting the stock could see over 20% upside in the coming year.
- Industry ranking context: DINO is currently the #1 highest-rated stock in the Oil & Gas Refining & Marketing industry, which has an Industry Rating of A.
- Zen Ratings highlights: DINO earns an overall A rating, which is equal to a Strong Buy recommendation. Stocks in this topmost tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
- Component Grades: DINO excels with As for Artificial Intelligence, Momentum, Growth, and Value, a rare four-A combination reflecting accelerating business trends, a powerful price uptrend, and a valuation that hasn't caught up to them, while maintaining strong Bs for Financials and Sentiment, positioning it well for continued appreciation. See all 7 Component Grades here
2. Marathon Petroleum (NYSE: MPC)
With strong refining assets and improving operational efficiency, this energy company is capitalizing on robust demand and favorable crack spreads in the energy sector.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $309.24 — get current quote
Max 1-year forecast: $376.00
Why we're watching:
- MPC has solid, bullish coverage among the analysts we track, with 7 Strong Buy, 3 Buy, and 4 Hold recommendations. See all recommendations here
- For example, Goldman Sachs researcher Neil Mehta (a top 5% rated analyst) recently maintained his Strong Buy rating with a price target suggesting over 20% upside potential in the coming year.
- Industry ranking context: MPC is currently the #4 highest-rated stock in the Oil & Gas Refining & Marketing industry, which has an Industry Rating of A.
- Zen Ratings highlights: MPC earns an overall A rating, which amounts to a Strong Buy recommendation. This tier represents the elite top 5% of stocks tracked based on a rigorous 115-factor fundamental review.
- Component Grades: MPC excels with As for Growth, Momentum, and Sentiment, reflecting strong market momentum and positive analyst reception, while maintaining a solid B for Value. See all 7 Component Grades here
3. Bioventus (NASDAQ: BVS)
Ranked #1 in the entire Zen Ratings system, this medical device company is positioned to capitalize on growing demand in orthopedic and pain relief markets.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $11.80 — get current quote
Max 1-year forecast: $16.00
Why we're watching:
- BVS has limited, but overall bullish, coverage among the analysts we track, with 1 Strong Buy and 2 Buy recommendations. See all recommendations here
- For example, Canaccord Genuity researcher Caitlin Cronin (a top 16% rated analyst) recently maintained her Strong Buy rating with a price target that suggests the stock could see nearly 30% upside in the coming year.
- On top of that, BVS is our most recent Stock of the Week selection. In his commentary, Zen Investor Editor-in-Chief Steve Reitmeister highlighted the stock’s elite ranking in our quant system (#1 out of over 4600 stocks based on fundamentals!) and how it is benefiting from multiple tailwinds. See his full writeup here.
- Industry ranking context: BVS is currently the #1 highest-rated stock in the Medical Device industry, which has an Industry Rating of C.
- Zen Ratings highlights: BVS earns an overall A rating, which amounts to a Strong Buy recommendation. Stocks with this rating represent the elite top 5% of all stocks tracked based on a rigorous 115-factor fundamental review.
- Component Grades: BVS excels with As for Growth and Sentiment, reflecting strong expansion potential and positive market reception, while maintaining solid Bs for Financials, Safety, and Value. See all 7 Component Grades here
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.